News

Trius said that it may receive up to $29.5m in support of development efforts under the new DTRA contract, which is funded as part of DTRA’s Transformational Medical

Medtronic RESCUE (Evaluation of the Clinical PeRformanceE of the Valiant Thoracic Stent Graft with the Captivia Delivery System for the EndovaSCUlar TrEatment of Blunt Thoracic Aortic Injuries) clinical

Hybrigenics said that the clinical tolerance observed at high and frequent exposure to Inecalcitol is positive. This makes it possible to consider other potential therapeutic indications such as

Abbott said that the latest approval for the Prism analyzer marks the completion of its full menu of blood screening tests, which includes assays for hepatitis, HIV and

Reportedly, Ablynx had signed the research collaboration and license agreement with Pfizer (originally signed with Wyeth Pharmaceuticals) in November 2006, a deal potentially worth $212.5m in past and

Galapagos claimed that GLPG0492 is an orally available small molecule that has been developed in its Selective Androgen Receptor Modulator (SARM) program. The candidate drug has been shown

EraGen’s HSV 1&2 Kit is expected to distinguish between HSV-1 and HSV-2 in vaginal lesion specimens from symptomatic female patients. This is critical to the diagnosis and treatment

The patent, titled ‘Treating Neoplasms with Neurotoxin,’ outlines the use of botulinum toxin around the cancer cell to decrease the contractile forces of the muscles surrounding a neoplasm

Inviragen’s DENVax investigational vaccine, developed by researchers at the CDC’s division of Vector-Borne Diseases, is based on an attenuated DEN-2 virus that generates long-lasting anti-dengue immune responses. CDC